I was around in May 2006 and at that time there was no drug in the pipeline. A good concept had been developed and, pre-GFC, it was hoped a major pharma would grab the concept. Post-GFC and most big companies changed their investment risk profiles and PYC languished for a long time. This time is very different - new leadership, drugs in pipeline, clear strategy and a much clearer understanding of the technology capabilities.
I was around in May 2006 and at that time there was no drug in...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 12.0¢ | $279.9K | 2.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 147929 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 834773 | 5 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |